News

ZURICH, Sept. 4, 2025 /PRNewswire/ -- AL-S Pharma today announced positive topline results from the Phase 2 clinical study evaluating AP-101, a potential first-in-class, disease-modifying treatment ...
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
MADRID (AP) — The extremely hot, dry and windy conditions, which fueled one of the IberianPeninsula’s most destructive wildfire seasons in recorded history, were 40 times more likely due to climate ...